Zobrazeno 1 - 10
of 16
pro vyhledávání: '"Kana Tsuchimoto"'
Autor:
Takayuki Hishiki, Takeshi Morita, Daisuke Akazawa, Hirofumi Ohashi, Eun-Sil Park, Michiyo Kataoka, Junki Mifune, Kaho Shionoya, Kana Tsuchimoto, Shinjiro Ojima, Aa Haeruman Azam, Shogo Nakajima, Madoka Kawahara, Tomoki Yoshikawa, Masayuki Shimojima, Kotaro Kiga, Ken Maeda, Tadaki Suzuki, Hideki Ebihara, Yoshimasa Takahashi, Koichi Watashi
Publikováno v:
Microbiology Spectrum, Vol 11, Iss 4 (2023)
ABSTRACT Mpox virus (formerly monkeypox virus [MPXV]) is a neglected zoonotic pathogen that caused a worldwide outbreak in May 2022. Given the lack of an established therapy, the development of an anti-MPXV strategy is of vital importance. To identif
Externí odkaz:
https://doaj.org/article/9162094e82eb4dd4b7a19db6b082afe0
Publikováno v:
Journal of Physical Fitness and Sports Medicine, Vol 11, Iss 1, Pp 21-28 (2022)
In order to clarify the acute effects of exercise on the cold sensory function of cold-sensitive women, 12 young adult females with an awareness of cold constitution were subjected to two experiments: an exercise condition in which cycle exercise wit
Externí odkaz:
https://doaj.org/article/f83afbe9446c4492a940339d80bd1e5a
Autor:
Wakana Saso, Masako Yamasaki, Shin-Ichi Nakakita, Shuetsu Fukushi, Kana Tsuchimoto, Noriyuki Watanabe, Nongluk Sriwilaijaroen, Osamu Kanie, Masamichi Muramatsu, Yoshimasa Takahashi, Tetsuro Matano, Makoto Takeda, Yasuo Suzuki, Koichi Watashi
Publikováno v:
PLoS Pathogens, Vol 18, Iss 6, p e1010590 (2022)
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has been transmitted across all over the world, in contrast to the limited epidemic of genetically- and virologically-related SARS-CoV. However, the molecular basis explaining the differenc
Externí odkaz:
https://doaj.org/article/6b10f0b116944715b5ff408429413a95
Autor:
Daisuke Akazawa, Hirofumi Ohashi, Takayuki Hishiki, Takeshi Morita, Shoya Iwanami, Kwang Su Kim, Yong Dam Jeong, Eun-Sil Park, Michiyo Kataoka, Kaho Shionoya, Junki Mifune, Kana Tsuchimoto, Shinjiro Ojima, Aa Haeruman Azam, Shogo Nakajima, Hyeongki Park, Tomoki Yoshikawa, Masayuki Shimojima, Kotaro Kiga, Shingo Iwami, Ken Maeda, Tadaki Suzuki, Hideki Ebihara, Yoshimasa Takahashi, Koichi Watashi
Publikováno v:
The Journal of Infectious Diseases.
Background Mpox virus (MPXV) is a zoonotic orthopoxvirus and caused an outbreak in 2022. Although tecovirimat and brincidofovir are approved as anti-smallpox drugs, their effects in mpox patients have not been well documented. In this study, by a dru
Autor:
Hirofumi Ohashi, Feng Wang, Frank Stappenbeck, Kana Tsuchimoto, Chisa Kobayashi, Wakana Saso, Michiyo Kataoka, Masako Yamasaki, Kouji Kuramochi, Masamichi Muramatsu, Tadaki Suzuki, Camille Sureau, Makoto Takeda, Takaji Wakita, Farhad Parhami, Koichi Watashi
Publikováno v:
International Journal of Molecular Sciences, Vol 22, Iss 6, p 3163 (2021)
The development of effective antiviral drugs targeting the severe acute respiratory syndrome-related coronavirus 2 (SARS-CoV-2) is urgently needed to combat the coronavirus disease 2019 (COVID-19). We have previously studied the use of semi-synthetic
Externí odkaz:
https://doaj.org/article/a998174f28e94e449274955719896c32
Autor:
Takayuki Hishiki, Takeshi Morita, Daisuke Akazawa, Hirofumi Ohashi, Eun-Sil Park, Michiyo Kataoka, Junki Mifune, Kaho Shionoya, Kana Tsuchimoto, Shinjiro Ojima, Aa Haeruman Azam, Shogo Nakajima, Tomoki Yoshikawa, Masayuki Shimojima, Kotaro Kiga, Ken Maeda, Tadaki Suzuki, Hideki Ebihara, Yoshimasa Takahashi, Koichi Watashi
Monkeypox virus (MPXV) is a neglected zoonotic pathogen that caused a worldwide outbreak in May 2022. Given the lack of an established therapy, the development of an anti-MPXV strategy is of vital importance. To identify drug targets for the developm
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::017641fdfcae0020c6f42a664b7a7125
https://doi.org/10.1101/2022.12.26.521968
https://doi.org/10.1101/2022.12.26.521968
Autor:
Daisuke Akazawa, Hirofumi Ohashi, Takayuki Hishiki, Takeshi Morita, Shoya Iwanami, Kwang Su Kim, Yong Dam Jeong, Eun-Sil Park, Michiyo Kataoka, Kaho Shionoya, Junki Mifune, Kana Tsuchimoto, Shinjiro Ojima, Aa Haeruman Azam, Shogo Nakajima, Hyeongki Park, Tomoki Yoshikawa, Masayuki Shimojima, Kotaro Kiga, Shingo Iwami, Ken Maeda, Tadaki Suzuki, Hideki Ebihara, Yoshimasa Takahashi, Koichi Watashi
Monkeypox virus (MPXV) is a zoonotic orthopoxvirus that causes smallpox-like symptoms in humans and caused an outbreak in May 2022 that led the WHO to declare global health emergency. In this study, from a screening of approved-drug libraries using a
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::5c9eb22f3943b95cff78e28ecb0bcdee
https://doi.org/10.1101/2022.08.02.502485
https://doi.org/10.1101/2022.08.02.502485
Autor:
Wakana Saso, Masako Yamasaki, Shin-ichi Nakakita, Shuetsu Fukushi, Kana Tsuchimoto, Noriyuki Watanabe, Nongluk Sriwilaijaroen, Osamu Kanie, Masamichi Muramatsu, Yoshimasa Takahashi, Tetsuro Matano, Makoto Takeda, Yasuo Suzuki, Koichi Watashi
Publikováno v:
PLoS pathogens. 18(6)
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has been transmitted across all over the world, in contrast to the limited epidemic of genetically- and virologically-related SARS-CoV. However, the molecular basis explaining the differenc
Autor:
Hirofumi Ohashi, Takayuki Hishiki, Daisuke Akazawa, Kwang Su Kim, Joohyeon Woo, Kaho Shionoya, Kana Tsuchimoto, Shoya Iwanami, Saya Moriyama, Hitomi Kinoshita, Souichi Yamada, Yudai Kuroda, Tsukasa Yamamoto, Noriko Kishida, Shinji Watanabe, Hideki Hasegawa, Hideki Ebihara, Tadaki Suzuki, Ken Maeda, Shuetsu Fukushi, Yoshimasa Takahashi, Shingo Iwami, Koichi Watashi
Publikováno v:
Antiviral Research. 205:105372
SummaryThe severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) Omicron subvariant BA.2 has spread in many countries, replacing the earlier Omicron subvariant BA.1 and other variants. Here, using a cell culture infection assay, we quantified
Autor:
Kouji Kuramochi, Tadaki Suzuki, Camille Sureau, Farhad Parhami, Wakana Saso, Masamichi Muramatsu, Takaji Wakita, Chisa Kobayashi, Masako Yamasaki, Feng Wang, Kana Tsuchimoto, Michiyo Kataoka, Koichi Watashi, Makoto Takeda, Hirofumi Ohashi, Frank Stappenbeck
Publikováno v:
International Journal of Molecular Sciences
International Journal of Molecular Sciences, Vol 22, Iss 3163, p 3163 (2021)
Volume 22
Issue 6
International Journal of Molecular Sciences, Vol 22, Iss 3163, p 3163 (2021)
Volume 22
Issue 6
The development of effective antiviral drugs targeting the severe acute respiratory syndrome-related coronavirus 2 (SARS-CoV-2) is urgently needed to combat the coronavirus disease 2019 (COVID-19). We have previously studied the use of semi-synthetic